Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thellung

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Discovery|September 7, 2016
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphomaFederica Barbieri, Adriana Bajetto, Stefano Thellung, et al.
International Journal of Molecular Sciences|September 4, 2012
Role of prion protein aggregation in neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Journal of Neuroscience Research|September 25, 1997
TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic deathA Scorziello, T Florio, A Bajetto, et al.
Neurochemical Research|March 1, 1997
Ca(2+)-ATPase pump forms and an endogenous inhibitor in bovine brain synaptosomesI Panfoli, L Musante, A Morelli, et al.
Journal of Neurochemistry|March 1, 1993
Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortexG Maura, S Thellung, G C Andrioli, et al.
Stem Cells Translational Medicine|June 17, 2020
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversiesAdriana Bajetto, Stefano Thellung, Irene Dellacasagrande, et al.
Journal of Molecular Endocrinology|December 22, 1999
A novel mechanism for the melatonin inhibition of testosterone secretion by rat Leydig cells: reduction of GnRH-induced increase in cytosolic Ca2+S Valenti, S Thellung, T Florio, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Journal of Neurochemistry|November 24, 2007
Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertionEmiliano Biasini, Andrea Z Medrano, Stefano Thellung, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Discovery|September 7, 2016
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphomaFederica Barbieri, Adriana Bajetto, Stefano Thellung, et al.
International Journal of Molecular Sciences|September 4, 2012
Role of prion protein aggregation in neurotoxicityAlessandro Corsaro, Stefano Thellung, Valentina Villa, et al.
Journal of Neuroscience Research|September 25, 1997
TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic deathA Scorziello, T Florio, A Bajetto, et al.
Neurochemical Research|March 1, 1997
Ca(2+)-ATPase pump forms and an endogenous inhibitor in bovine brain synaptosomesI Panfoli, L Musante, A Morelli, et al.
Journal of Neurochemistry|March 1, 1993
Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortexG Maura, S Thellung, G C Andrioli, et al.
Stem Cells Translational Medicine|June 17, 2020
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversiesAdriana Bajetto, Stefano Thellung, Irene Dellacasagrande, et al.
Journal of Molecular Endocrinology|December 22, 1999
A novel mechanism for the melatonin inhibition of testosterone secretion by rat Leydig cells: reduction of GnRH-induced increase in cytosolic Ca2+S Valenti, S Thellung, T Florio, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Frontiers in Neuroscience|September 23, 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targetsStefano Thellung, Alessandro Corsaro, Irene Dellacasagrande, et al.
Journal of Neurochemistry|November 24, 2007
Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertionEmiliano Biasini, Andrea Z Medrano, Stefano Thellung, et al.
Pageof 10